Aggressive prostate cancer risk:Score:Pt: Patient:Qn:Calculated.ExoDx

Preferred Label : Aggressive prostate cancer risk:Score:Pt: Patient:Qn:Calculated.ExoDx;

LOINC status : ACTIVE;

LOINC display name : Aggressive prostate cancer risk Calculated by ExoDx [Score];

LOINC long common name : Aggressive prostate cancer risk [Score] by Calculated by ExoDx;

LOINC short name : Aggr PC risk Score Patient Calc.ExoDx;

LOINC description : This term was developed for ExoDx Prostate Test (IntelliScore). The ExoDx Prostate Test is a reverse-transcription PCR analysis of the genes PCA3, ERG, and SPDEF in urine. The ExoDx's IntelliScore is calculated based on a proprietary algorithm that uses PCA3, ERG, and SPDEF molecular results. The score is used to surmise the patient's risk of aggressive prostate cancer and help determine whether or not a biopsy should be performed. [PMID: 30129068] The ExoDx Prostate Test differentiates high and low grade cancer from benign diseases, using a cutoff score of 15.6. Patients with an Intelliscore above 15.6 are recommended for biopsy. [PMID: 27032035];

Details

Origin ID

95130-1;

UMLS CUI

C5381638;

Has component
- Aggressive prostate cancer risk [LOINC component]
- Cancer [LOINC component]
- Prostate cancer risk [LOINC component]
Has method
- Calculated [LOINC method]
- Calculated by ExoDx [LOINC method]
Has property
- Score [LOINC Property]
Has system
- Patient [LOINC System]
- ^Patient [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients